A totally implanted venous access system for the delivery of chemotherapy
- 1 September 1985
- Vol. 56 (5) , 1231-1234
- https://doi.org/10.1002/1097-0142(19850901)56:5<1231::aid-cncr2820560546>3.0.co;2-6
Abstract
The use of an Ommaya Capsule-Catheter System for the delivery of chemotherapy in cancer patients with inadequate peripheral veins has been studied over a 6-year period. Between 1978 and 1984, 76 Ommaya capsules were implanted in 68 patients, providing a collective experience of over 28,000 venous access days. Two patients were lost to follow-up. The results of the capsule-catheter system performance indicates a functional rate of over 90%. The complications included a 6.7% catheter occlusion rate, and a 2.7% capsule leakage rate. This accounts for an overall catheter related complication rate of 9.4%.This publication has 16 references indexed in Scilit:
- Prolonged venous access for chemotherapy by means of the hickman catheterCancer, 2006
- Totally implantable venous access system for cyclic administration of cytotoxic chemotherapyThe American Journal of Surgery, 1984
- Implantable central venous access systemThe American Journal of Surgery, 1984
- Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancyCancer, 1983
- Hickman Catheter Implantation in the Treatment of Acute LeukemiaArchives of Surgery, 1983
- Percutaneous placement of Hickman catheters for prolonged venous accessThe American Journal of Surgery, 1982
- Risk of infection associated with the use of Broviac and Hickman cathetersAmerican Journal of Infection Control, 1982
- Hickman-Broviac catheters: Indications and resultsThe American Journal of Surgery, 1980
- Vascular access for cancer chemotherapyCancer, 1979
- Long-term intravenous therapy with peripherally inserted silicone elastomer central venous catheters in patients with malignant diseasesCancer, 1979